Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Bio‐Inspired and Smart Nanoparticles for Triple Negative Breast Cancer Microenvironment Publisher



Shokooh MK1 ; Emami F2 ; Jeong JH3 ; Yook S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutics, College of Pharmacy, Tehran University of Medical Sciences, Tehran, 1417614411, Iran
  2. 2. College of Pharmacy, Keimyung University, Daegu, 42601, South Korea
  3. 3. College of Pharmacy, Yeungnam University, Gyeongsan, Gyeongbuk, 38541, South Korea

Source: Pharmaceutics Published:2021


Abstract

Triple negative breast cancer (TNBC) with poor prognosis and aggressive nature accounts for 10–20% of all invasive breast cancer (BC) cases and is detected in as much as 15% of individuals diagnosed with BC. Currently, due to the absence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2) receptor, there is no hormone‐based therapy for TNBC. In addition, there are still no FDA‐approved targeted therapies for patients with TNBC. TNBC treatment is challenging owing to poor prognosis, tumor heterogeneity, chemotherapeutic side effects, the chance of metastasis, and multiple drug‐resistance. Therefore, various bio‐inspired tumor‐homing nano systems responding to intra‐ and extra‐ cellular stimuli are an urgent need to treat TNBC patients who do not respond to current chemotherapy. In this review, intensive efforts have been made for exploring cell‐membrane coated nanoparticles and immune cell‐targeted nanoparticles (immunotherapy) to modulate the tumor microenvironment and deliver accurate amounts of therapeutic agents to TNBC without stimulating the immune system. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Related Docs
View other Related Docs
1. Triple-Negative Breast Cancer Treatment Meets Nanoparticles: Current Status and Future Direction, Journal of Drug Delivery Science and Technology (2022)
2. Tumor Immunology, Clinical Immunology (2022)
3. Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review, Pharmacological Reviews (2023)
4. Biomimetic Nanotechnology for Cancer Immunotherapy: State of the Art and Future Perspective, International Journal of Pharmaceutics (2024)
5. Polymeric Nanoparticles As a Promising Platform for Treating Triple-Negative Breast Cancer: Current Status and Future Perspectives, International Journal of Pharmaceutics (2024)
6. Resveratrol As an Adjuvant for Normal Tissues Protection and Tumor Sensitization, Current Cancer Drug Targets (2020)
7. Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report From Cancer Institute of Iran, International Journal of Hematology-Oncology and Stem Cell Research (2017)
8. The Prognostic and Therapeutic Value and Clinical Implications of Fibroblast Activation Protein-Α As a Novel Biomarker in Colorectal Cancer, Cell Communication and Signaling (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (7)
Hamid Reza Mirzaei (1)
Other Related Docs
9. Lactic Acid in Macrophage Polarization: A Factor in Carcinogenesis and a Promising Target for Cancer Therapy, Biochemical Pharmacology (2024)
10. The Tale of Tils in Breast Cancer: A Report From the International Immuno-Oncology Biomarker Working Group, npj Breast Cancer (2021)
11. Photothermic Therapy With Cuttlefish Ink-Based Nanoparticles in Combination With Anti-Ox40 Mab Achieve Remission of Triple-Negative Breast Cancer, International Immunopharmacology (2023)
12. Recent Advances in Porphyrin-Based Nanocomposites for Effective Targeted Imaging and Therapy, Biomaterials (2020)
13. Immunopathology and Immunotherapy for Breast Cancer, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
14. Current Therapeutic Approaches and Promising Perspectives of Using Bioengineered Peptides in Fighting Chemoresistance in Triple-Negative Breast Cancer, Biochemical Pharmacology (2023)
15. Mir-130A-3P Blocks Wnt Signaling Cascade in the Triple-Negative Breast Cancer by Targeting the Key Players at Multiple Points, Heliyon (2020)
16. In Vivo Drug Delivery Applications of Nanogels: A Review, Nanomedicine (2020)
17. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
18. New Approaches in Cancer Immunotherapy: Review Article, Tehran University Medical Journal (2018)
19. Immunotherapy for Breast Cancer Treatment, Iranian Biomedical Journal (2021)
20. Graphene-Based Nanomaterials for Stimuli-Sensitive Controlled Delivery of Therapeutic Molecules, Frontiers in Bioengineering and Biotechnology (2023)
21. A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular Rnas, Frontiers in Cell and Developmental Biology (2020)
22. Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer: From Immunological Mechanisms to Clinical Evidence, International Immunopharmacology (2021)
23. Glyco-Nanoparticles: New Drug Delivery Systems in Cancer Therapy, Seminars in Cancer Biology (2021)
24. Overexpression of Gabrp Gene in Triple Negative Breast Cancer: Molecular Mechanisms and Interpretation, International Journal of Cancer Management (2021)